Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease

Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams, Sven Mensing, Roopal B. Thakkar, Anne M. Robinson, Joel R. Rosh, Frank M. Ruemmele, Walid M. Awni
  • Inflammatory Bowel Diseases, April 2015, Wolters Kluwer Health
  • DOI: 10.1097/mib.0000000000000327
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Allison M Kitten